Vaxart Return On Asset vs. Market Capitalization
| VXRT Stock | USD 0.60 0.01 1.64% |
For Vaxart profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Vaxart to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Vaxart Inc utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Vaxart's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Vaxart Inc over time as well as its relative position and ranking within its peers.
Vaxart |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Vaxart. If investors know Vaxart will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Vaxart listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.40) | Revenue Per Share 0.085 | Quarterly Revenue Growth 3.714 | Return On Assets (0.40) | Return On Equity (0.92) |
The market value of Vaxart Inc is measured differently than its book value, which is the value of Vaxart that is recorded on the company's balance sheet. Investors also form their own opinion of Vaxart's value that differs from its market value or its book value, called intrinsic value, which is Vaxart's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Vaxart's market value can be influenced by many factors that don't directly affect Vaxart's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Vaxart's value and its price as these two are different measures arrived at by different means. Investors typically determine if Vaxart is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Vaxart's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Vaxart Inc Market Capitalization vs. Return On Asset Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Vaxart's current stock value. Our valuation model uses many indicators to compare Vaxart value to that of its competitors to determine the firm's financial worth. Vaxart Inc is rated fourth in return on asset category among its peers. It is rated third in market capitalization category among its peers . At this time, Vaxart's Market Cap is comparatively stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Vaxart by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Vaxart Market Capitalization vs. Return On Asset
Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Vaxart |
| = | -0.4 |
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
Market Capitalization is the total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.
Vaxart |
| = | 136.33 M |
In most publications or references market cap is broken down into the mega-cap, large-cap, mid-cap, small-cap, micro-cap, and nano-cap. Market Cap is a measurement of business as total market value of all of the outstanding shares at a given time, and can be used to compare different companies based on their size.
Vaxart Market Capitalization vs Competition
Vaxart Inc is rated third in market capitalization category among its peers. Market capitalization of Health Care industry is at this time estimated at about 1.85 Billion. Vaxart holds roughly 136.33 Million in market capitalization claiming about 7% of equities under Health Care industry.
Vaxart Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Vaxart, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Vaxart will eventually generate negative long term returns. The profitability progress is the general direction of Vaxart's change in net profit over the period of time. It can combine multiple indicators of Vaxart, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | (1,000.00) | (1,050) | |
| Operating Income | -83.3 M | -79.2 M | |
| Income Before Tax | -82.2 M | -78.1 M | |
| Total Other Income Expense Net | 1.1 M | 1 M | |
| Net Loss | -82.5 M | -78.3 M | |
| Income Tax Expense | 261 K | 440.2 K | |
| Net Loss | -82.5 M | -78.3 M | |
| Non Operating Income Net Other | -5.4 K | -5.1 K | |
| Net Loss | -97 M | -92.1 M | |
| Net Interest Income | 1.2 M | 1.3 M | |
| Interest Income | 2.7 M | 2.8 M | |
| Change To Netincome | 20.5 M | 21.5 M | |
| Net Loss | (0.57) | (0.60) | |
| Income Quality | 0.85 | 0.81 | |
| Net Income Per E B T | 1.00 | 0.62 |
Vaxart Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Vaxart. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Vaxart position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Vaxart's important profitability drivers and their relationship over time.
Use Vaxart in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Vaxart position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vaxart will appreciate offsetting losses from the drop in the long position's value.Vaxart Pair Trading
Vaxart Inc Pair Trading Analysis
The ability to find closely correlated positions to Vaxart could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Vaxart when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Vaxart - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Vaxart Inc to buy it.
The correlation of Vaxart is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Vaxart moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Vaxart Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Vaxart can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Vaxart position
In addition to having Vaxart in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Recreation Thematic Idea Now
Recreation
Companies involved in production and services of recreational goods, foods, and accessories. The Recreation theme has 39 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Recreation Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Vaxart Stock Analysis
When running Vaxart's price analysis, check to measure Vaxart's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vaxart is operating at the current time. Most of Vaxart's value examination focuses on studying past and present price action to predict the probability of Vaxart's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vaxart's price. Additionally, you may evaluate how the addition of Vaxart to your portfolios can decrease your overall portfolio volatility.